NM_001918.5:c.*9082C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001918.5(DBT):​c.*9082C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.117 in 152,132 control chromosomes in the GnomAD database, including 1,397 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1397 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

DBT
NM_001918.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.326

Publications

4 publications found
Variant links:
Genes affected
DBT (HGNC:2698): (dihydrolipoamide branched chain transacylase E2) The branched-chain alpha-keto acid dehydrogenase complex (BCKD) is an inner-mitochondrial enzyme complex involved in the breakdown of the branched-chain amino acids isoleucine, leucine, and valine. The BCKD complex is thought to be composed of a core of 24 transacylase (E2) subunits, and associated decarboxylase (E1), dehydrogenase (E3), and regulatory subunits. This gene encodes the transacylase (E2) subunit. Mutations in this gene result in maple syrup urine disease, type 2. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
DBT Gene-Disease associations (from GenCC):
  • maple syrup urine disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • maple syrup urine disease type 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P, Myriad Women’s Health
  • classic maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermittent maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thiamine-responsive maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 1-100187173-G-A is Benign according to our data. Variant chr1-100187173-G-A is described in ClinVar as Benign. ClinVar VariationId is 291375.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001918.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DBT
NM_001918.5
MANE Select
c.*9082C>T
3_prime_UTR
Exon 11 of 11NP_001909.4P11182
DBT
NM_001399969.1
c.*9082C>T
3_prime_UTR
Exon 12 of 12NP_001386898.1A0A7P0T9W1
DBT
NM_001399972.1
c.*9082C>T
3_prime_UTR
Exon 12 of 12NP_001386901.1A0A7P0T9W1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DBT
ENST00000370132.8
TSL:1 MANE Select
c.*9082C>T
3_prime_UTR
Exon 11 of 11ENSP00000359151.3P11182
DBT
ENST00000875462.1
c.*42-4046C>T
intron
N/AENSP00000545521.1
ENSG00000285530
ENST00000835180.1
n.139+20230G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.117
AC:
17822
AN:
152014
Hom.:
1396
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0317
Gnomad AMI
AF:
0.197
Gnomad AMR
AF:
0.118
Gnomad ASJ
AF:
0.154
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0319
Gnomad FIN
AF:
0.144
Gnomad MID
AF:
0.206
Gnomad NFE
AF:
0.176
Gnomad OTH
AF:
0.140
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.117
AC:
17822
AN:
152132
Hom.:
1397
Cov.:
32
AF XY:
0.113
AC XY:
8408
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.0316
AC:
1314
AN:
41532
American (AMR)
AF:
0.118
AC:
1799
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.154
AC:
534
AN:
3470
East Asian (EAS)
AF:
0.000772
AC:
4
AN:
5184
South Asian (SAS)
AF:
0.0321
AC:
155
AN:
4826
European-Finnish (FIN)
AF:
0.144
AC:
1517
AN:
10544
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.176
AC:
11965
AN:
67984
Other (OTH)
AF:
0.138
AC:
292
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
781
1563
2344
3126
3907
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.154
Hom.:
388
Bravo
AF:
0.113
Asia WGS
AF:
0.0240
AC:
84
AN:
3470

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Maple syrup urine disease (2)
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
3.1
DANN
Benign
0.54
PhyloP100
0.33
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72728160; hg19: chr1-100652729; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.